|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-2-4
|
|
pubmed:abstractText |
Up to the present date, the treatment of recurrent chronic fistulas occurring with Crohn's disease represents a challenging task for both internists and surgeons alike.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9867
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
195-200
|
|
pubmed:meshHeading |
pubmed-meshheading:19122456-Adult,
pubmed-meshheading:19122456-Antibodies, Monoclonal,
pubmed-meshheading:19122456-Crohn Disease,
pubmed-meshheading:19122456-Gastrointestinal Agents,
pubmed-meshheading:19122456-Humans,
pubmed-meshheading:19122456-Purpura, Thrombocytopenic, Idiopathic,
pubmed-meshheading:19122456-Rectal Fistula,
pubmed-meshheading:19122456-Remission Induction,
pubmed-meshheading:19122456-Treatment Outcome,
pubmed-meshheading:19122456-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
|
|
pubmed:affiliation |
Department of Internal Medicine I, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany. Thomas.deRossi@uk-erlangen.de
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
